Written by the Nuvirox Research Team
Key Points
- A 2022 randomized, double-blind, placebo-controlled trial found myo-inositol supplementation improved global sleep quality, subjective sleep quality, and sleep duration — but the study population was pregnant women specifically.
- Inositol's proposed mechanism involves its role as a secondary messenger in cell signaling pathways that affect neurotransmitters like serotonin, which is upstream of melatonin production.
- As of this review, dedicated randomized trials testing inositol for sleep in a general, non-pregnant adult population were not located, which meaningfully limits how confidently the pregnancy finding generalizes.
Short answer: the one dedicated randomized trial on inositol and sleep found a real, statistically significant benefit — in pregnant women specifically, which is a genuinely different population than most people reading a sleep supplement label. Here's an honest look at what that trial found and where the evidence gap sits.
What is inositol, and why would it affect sleep?
Inositol is a naturally occurring, sugar-like compound found in the body and in foods like citrus fruits and beans. It functions as a secondary messenger in the phosphatidylinositol signaling system, a cellular pathway involved in how neurons respond to neurotransmitters, including serotonin, which is itself a precursor in the pathway that eventually produces melatonin. It's more commonly known in supplement contexts for its use in fertility and PCOS-related research than for sleep, which makes its appearance in sleep-focused research somewhat newer territory.
What did the dedicated sleep trial actually test?
The relevant study is a 2022 randomized, double-blind, placebo-controlled trial published in the Journal of Maternal-Fetal & Neonatal Medicine, involving 60 pregnant women with low-risk singleton pregnancies. Participants received either 2,000 mg of myo-inositol plus 200 mcg of folic acid, or a folic acid-only placebo, daily for 10 weeks, from roughly 14 to 24 weeks of pregnancy. Sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI), a validated, widely used tool.
The trial found statistically significant improvements in global sleep quality, subjective sleep quality, sleep duration, and habitual sleep efficiency in the myo-inositol group compared to placebo. This is a real, randomized, placebo-controlled result — not an observational correlation — which puts it on firmer footing than a lot of the emerging-ingredient research covered in this kind of review.
Why does the population studied matter so much here?
Pregnancy involves substantial hormonal, metabolic, and sleep-architecture changes that don't necessarily apply to a non-pregnant adult dealing with ordinary sleep-onset difficulty. A mechanism that helps regulate sleep disruption tied to pregnancy-specific physiology isn't automatically going to produce the same effect in someone whose sleep issue has an entirely different cause, like stress, an irregular schedule, or aging-related sleep changes. This is one of the more important distinctions in reading supplement research honestly: a real, well-designed trial in one specific population is meaningful evidence for that population, and a reasonable but unproven hypothesis for anyone outside it.
What human studies actually show
Mashayekh-Amiri et al., 2022, Journal of Maternal-Fetal & Neonatal Medicine (n=60, randomized, double-blind, placebo-controlled). Myo-inositol (2,000 mg/day) plus folic acid significantly improved PSQI-measured sleep quality, sleep duration, and sleep efficiency in pregnant women over 10 weeks, compared to folic-acid-only placebo.
Honest counterweight: the trial's own limitations, noted by the authors, include a relatively small sample size (n=60) and a study population and design that don't address whether the effect would replicate in non-pregnant adults, in men, or over a longer duration. The authors explicitly called for larger studies to confirm the finding, which is itself a useful signal about how early-stage this specific research area still is.
Separately, inositol has research support in areas like anxiety and mood regulation, which provides a plausible, if indirect, reason it might extend to sleep more broadly — anxiety and sleep-onset difficulty are frequently linked. But plausible mechanism plus evidence in an adjacent area is not the same as a direct trial result, and it's worth being clear about which kind of support any individual claim about inositol is resting on.
What inositol won't do
Based on the current evidence, inositol shouldn't be expected to work as a general-population sleep aid with the same confidence as the specific pregnancy trial suggests for that population. If you're pregnant and considering any new supplement, including inositol, that should go through your OB-GYN or midwife first, since supplement safety and dosing during pregnancy involves considerations well beyond sleep quality alone.
Dosing, based on what was actually studied
The dose used in the pregnancy sleep trial was 2,000 mg of myo-inositol daily, paired with folic acid, over a 10-week period — a sustained-intake protocol, not a same-night dose. Because this is currently the only dedicated randomized sleep trial available, any inositol dosing recommendation for a general audience is necessarily an extrapolation from a study conducted in a different population, which is worth keeping in mind when comparing labeled doses across different products.
How does inositol's proposed mechanism relate to mood-sleep research generally?
Inositol's involvement in the phosphatidylinositol signaling pathway puts it in a category of compounds researchers have studied for mood and anxiety regulation, areas where sleep disruption and emotional regulation are frequently intertwined. Several small studies outside the sleep-specific literature have examined inositol for anxiety and mood-related symptoms, generally with modest, mixed results rather than a uniformly strong signal. This adjacent research doesn't substitute for a direct sleep trial, but it does help explain why researchers hypothesized a sleep connection in the first place, rather than the pregnancy trial being an isolated, out-of-nowhere finding.
It's also worth noting that inositol occurs naturally in a range of common foods, including citrus fruits, beans, and whole grains, meaning many people already consume a baseline amount through diet before ever considering a supplement. That's a different starting point than an ingredient like melatonin, which the body produces internally but doesn't obtain meaningfully from food, and it's part of why inositol research often distinguishes between supplementing on top of a typical diet versus correcting a more unusual, restricted intake pattern.
Frequently asked questions
Frequently asked questions
Does inositol help sleep in people who aren't pregnant?
There isn't yet a dedicated randomized trial testing this directly in a general adult population. The only specific sleep trial located was conducted in pregnant women, which limits how confidently the finding generalizes.
Is inositol the same as melatonin?
No. Inositol is a cell-signaling compound thought to influence neurotransmitter pathways upstream of melatonin production, while melatonin is the hormone directly responsible for sleep timing signals. It's a different mechanism than magnesium or other mineral cofactors, too. They work through entirely different mechanisms.
Is inositol safe to take during pregnancy?
The 2022 trial used inositol safely alongside folic acid in a supervised research setting, but any supplement decision during pregnancy should be made with your OB-GYN or midwife, not based on a single study.
What else is inositol commonly used for?
It has a longer research history in contexts like polycystic ovary syndrome (PCOS) and fertility support, and some research on mood and anxiety, similar in spirit to how GABA research also spans both anxiety and sleep, which is separate from its more recent, limited appearance in sleep research.
From Nuvirox
Why we formulated Sleep+ Restore
Sleep+ Restore includes inositol as part of its 905 mg proprietary blend, alongside melatonin and other researched botanicals — positioned as a supporting ingredient within a broader, multi-pathway formula rather than a standalone claim.
Learn more about Sleep+ Restore →The bottom line
Inositol has one genuinely solid randomized trial behind it for sleep — a real, statistically significant result, in a study designed and reported honestly about its own limits. The catch is that the population studied, pregnant women, is specific enough that the finding shouldn't be assumed to extend broadly until more research fills that gap.
References
- Mashayekh-Amiri S, Delavar MA, Bakouei F, Faramarzi M, Esmaeilzadeh S. The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study. J Matern Fetal Neonatal Med. 2022;35(18):3415-3423. PMID: 32933356.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.